Health ❯ Healthcare ❯ Chronic Diseases

Type 2 Diabetes

Management Strategies Treatment Options Management and Treatment Medication Effects Weight Management Obesity Cardiovascular Risk Blood Sugar Regulation Management Dementia Risk Tobacco Use Disorder Cardiovascular Health Prevention and Management Impact on Youth Cardiometabolic Health Insulin Response Metabolic Syndrome Medication Comparison Obesity Management Insulin Sensitivity SGLT-2 Inhibitors Insulin Regulation Associated Conditions Obesity and Diabetes Connection

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

Researchers urge multi-year, cancer-focused trials to determine long-term effects.

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

17 Million U.S. Youth Eligible for GLP-1 Therapies Face Coverage and Care Barriers

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors

GLP-1 Agonists Cut Dementia and Mortality Risk Versus Metformin in Type 2 Diabetes